BSSFA
ZBH icon

Baron Silver Stevens Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

Baron Silver Stevens Financial Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-101
Closed -$15K – 506
2020
Q4 		$15K Buy
+101
New +$14.3K 0.01% 221

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baron Silver Stevens Financial Advisors's ZBH Position: Q1 2021 in Review

Baron Silver Stevens Financial Advisors sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 101 shares — an estimated $15K sold.

Baron Silver Stevens Financial Advisors first reported a position in ZBH in Q4 2020 and held it in 1 quarter. The position peaked at $15K in Q4 2020. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

  • Baron Silver Stevens Financial Advisors reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
  • Baron Silver Stevens Financial Advisors sold 101 Zimmer Biomet shares in Q1 2021, an estimated $15K.
  • Baron Silver Stevens Financial Advisors first reported a position in Zimmer Biomet in Q4 2020 and held it in 1 quarter.
  • Baron Silver Stevens Financial Advisors's Zimmer Biomet position peaked at $15K in Q4 2020.
  • 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q1 2021, filed 27 Apr 2021.